Marseille-Kliniken AG

euro adhoc: Marseille-Kliniken AG
other
- Further real estate deal signed - Sale of six care facilities for EUR 33.5 m

-------------------------------------------------------------------------------- Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- 30.06.2008 Adhoc Release in accordance with section 15 of the German Securities Trading Act (WpHG) Berlin, 30 June 2008. Marseille-Kliniken AG (Prime Standard, ISIN DE 0007783003, MKA) has signed a sale-and-lease-back deal with a consortium of real estate investors, IMMAC Holding AG, Hamburg, as well as RP&C International / Public Service Properties Investments Ltd., London. Marseille-Kliniken AG has agreed a long-term lease for six care properties with a total of 567 beds with the investor consortium. In total, the transaction has a volume of EUR 33.5 m and offers the company further financial scope to pursue its growth strategy in its core care business. About 20% of Marseille-Kliniken AG´s portfolio consists of facilities it uses itself and about 80% which it has leased to other providers. The transaction will further reduce the company´s long-term financial debt. The outlook for the financial year 2007/2008 dated 8 May 2008 is being confirmed. The company expects an annual turnover of EUR 233.5 m, an EBIT of EUR 24.0 m and a profit after tax of EUR 18.0 m. End of adhoc release end of announcement euro adhoc -------------------------------------------------------------------------------- ots Originaltext: Marseille-Kliniken AG Im Internet recherchierbar: http://www.presseportal.ch Further inquiry note: Marseille-Kliniken AG Axel Hölzer CEO Alte Jakobstraße 79/80 10709 Berlin GERMANY Tel.: +4930 / 246 32-400 Fax: +4930 / 246 32-401 www.marseille-kliniken.com or Hillermann Consulting Christian Hillermann Investor Relations for Marseille-Kliniken AG Poststraße 14/16 20354 Hamburg GERMANY Tel.: +4940 / 320 279 10 Fax: +4940 / 320 279 114 www.hillermann-consulting.de Branche: Pharmaceuticals ISIN: DE0007783003 WKN: 778300 Index: CDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Stuttgart / free trade Börse Düsseldorf / free trade Börse Hamburg / regulated dealing

Das könnte Sie auch interessieren: